News
2023-09-26
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Mölndal, Sweden Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, today announced the launch of a new service...
Events
June 6-7, 2023
Discovery Europe 2023
Discovery Europe and the Neuroscience Drug Development Europe meetings take place in parallel in Berlin, Germany on June 6-7, 2023....
Events
May 15-16, 2023
Neuro4D 2023
The Neuro4D conference takes place in Mainz, Germany on May 15-16, 2023. With a focus on drug discovery for proteopathic...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
March 28 - April 1, 2023
AD/PD 2023
The AD/PD 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Gothenburg, Sweden on...
News
2023-02-14
Delix Therapeutics partners with Cellectricon, Expressive Neuroscience and expands science team to accelerate drug discovery and translatability
We’re excited to be working with Delix Therapeutics and support their development of neuroplasticity-promoting therapeutics! At Cellectricon, we solve our...
News
2023-01-31
Cellectricon strengthens IP portfolio – Receives “Intention to Grant” from the European Patent Office
Cellectricon AB, a leading provider of neurobiology in vitro research services, today announced that the company received notice of intention...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
November 12-16, 2022
Neuroscience 2022
The Neuroscience 2022 meeeting takes place in San Diego on November 12-16. During the conference, we will present several posters...
Events
October 11, 2022
Nordic Health Meet 2022
Cellectricon are proud presenters at the Nordic Health Meet 2022 at the Embassy of Sweden in Tokyo on October 11....
Events
September 29, 2022
Webcast - Validation of an in vitro α-synuclein aggregation assay for target discovery in neurodegenerative disease research
Event info: In this webcast, Paul Karila, Head of Drug Discovery, and Johan Pihl, Chief Operating Officer, discuss the development...